Establishment of a Prognostic Model and Tumor Clustering for Pediatric Acute Myeloid Leukemia Patients: Leveraging the Fanconi Anemia Signaling Pathway to Enhance Clinical Management
In November 2023, a study led by Professor XiaoFan Zhu from Chinese Academy of Medical Sciences Blood Disease Hospital (Institute of Hematology, Chinese Academy of Medical Sciences) was published in the international academic journal ——Open Medicine(Wars). The title of the study is "Establishing a novel Fanconi anemia signaling pathway-associated prognostic model and tumor clustering for pediatric acute myeloid leukemia patients". This study heralds the establishment of a novel prognostic model and tumor clustering approach tailored specifically for pediatric AML, anchored in the FA signaling pathway.